Predictive Oncology Statistics
Total Valuation
POAI has a market cap or net worth of $9.47 million. The enterprise value is $10.86 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
POAI has 8.93 million shares outstanding. The number of shares has increased by 35.84% in one year.
| Current Share Class | 8.93M |
| Shares Outstanding | 8.93M |
| Shares Change (YoY) | +35.84% |
| Shares Change (QoQ) | +4.37% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | 2.70% |
| Float | 8.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.56 |
| Forward PS | 0.98 |
| PB Ratio | -46.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62
| Current Ratio | 0.62 |
| Quick Ratio | 0.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -269.18% and return on invested capital (ROIC) is -105.79%.
| Return on Equity (ROE) | -269.18% |
| Return on Assets (ROA) | -70.52% |
| Return on Invested Capital (ROIC) | -105.79% |
| Return on Capital Employed (ROCE) | -793.22% |
| Revenue Per Employee | $67,659 |
| Profits Per Employee | -$527,683 |
| Employee Count | 24 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.80% in the last 52 weeks. The beta is 1.11, so POAI's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -29.80% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 47.01 |
| Average Volume (20 Days) | 261,937 |
Short Selling Information
The latest short interest is 266,976, so 2.99% of the outstanding shares have been sold short.
| Short Interest | 266,976 |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 2.99% |
| Short % of Float | 3.03% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, POAI had revenue of $1.62 million and -$12.66 million in losses. Loss per share was -$2.32.
| Revenue | 1.62M |
| Gross Profit | 797,680 |
| Operating Income | -10.94M |
| Pretax Income | -14.78M |
| Net Income | -12.66M |
| EBITDA | -10.78M |
| EBIT | -10.94M |
| Loss Per Share | -$2.32 |
Full Income StatementBalance Sheet
The company has $734,673 in cash and $2.13 million in debt, giving a net cash position of -$1.40 million or -$0.16 per share.
| Cash & Cash Equivalents | 734,673 |
| Total Debt | 2.13M |
| Net Cash | -1.40M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | -202,610 |
| Book Value Per Share | -0.03 |
| Working Capital | -1.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.96 million and capital expenditures -$9,510, giving a free cash flow of -$11.97 million.
| Operating Cash Flow | -11.96M |
| Capital Expenditures | -9,510 |
| Free Cash Flow | -11.97M |
| FCF Per Share | -$1.34 |
Full Cash Flow StatementMargins
| Gross Margin | 49.12% |
| Operating Margin | -673.69% |
| Pretax Margin | -668.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |